Quest Diagnostics (DGX) Consolidated Net Income (2017 - 2025)
Quest Diagnostics (DGX) has disclosed Consolidated Net Income for 13 consecutive years, with $249.0 million as the latest value for Q4 2025.
- Quarterly Consolidated Net Income rose 7.79% to $249.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 11.31% year-over-year, with the annual reading at $1.0 billion for FY2025, 11.31% up from the prior year.
- Consolidated Net Income hit $249.0 million in Q4 2025 for Quest Diagnostics, down from $251.0 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $762.0 million in Q2 2021 to a low of $113.0 million in Q4 2022.
- Historically, Consolidated Net Income has averaged $294.2 million across 5 years, with a median of $244.0 million in 2022.
- Biggest five-year swings in Consolidated Net Income: plummeted 70.88% in 2022 and later surged 74.34% in 2023.
- Year by year, Consolidated Net Income stood at $388.0 million in 2021, then crashed by 70.88% to $113.0 million in 2022, then soared by 74.34% to $197.0 million in 2023, then rose by 17.26% to $231.0 million in 2024, then increased by 7.79% to $249.0 million in 2025.
- Business Quant data shows Consolidated Net Income for DGX at $249.0 million in Q4 2025, $251.0 million in Q3 2025, and $287.0 million in Q2 2025.